These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11320250)

  • 21. Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.
    Starita LM; Young DL; Islam M; Kitzman JO; Gullingsrud J; Hause RJ; Fowler DM; Parvin JD; Shendure J; Fields S
    Genetics; 2015 Jun; 200(2):413-22. PubMed ID: 25823446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.
    Brzovic PS; Lissounov A; Christensen DE; Hoyt DW; Klevit RE
    Mol Cell; 2006 Mar; 21(6):873-80. PubMed ID: 16543155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins.
    Irminger-Finger I; Siegel BD; Leung WC
    Biol Chem; 1999 Feb; 380(2):117-28. PubMed ID: 10195418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
    Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
    Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.
    Caleca L; Putignano AL; Colombo M; Congregati C; Sarkar M; Magliery TJ; Ripamonti CB; Foglia C; Peissel B; Zaffaroni D; Manoukian S; Tondini C; Barile M; Pensotti V; Bernard L; Papi L; Radice P
    PLoS One; 2014; 9(2):e86924. PubMed ID: 24516540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites.
    Polanowska J; Martin JS; Garcia-Muse T; Petalcorin MI; Boulton SJ
    EMBO J; 2006 May; 25(10):2178-88. PubMed ID: 16628214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
    Ye Q; Hu YF; Zhong H; Nye AC; Belmont AS; Li R
    J Cell Biol; 2001 Dec; 155(6):911-21. PubMed ID: 11739404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.
    Kim BJ; Chan DW; Jung SY; Chen Y; Qin J; Wang Y
    Cell Rep; 2017 May; 19(9):1758-1766. PubMed ID: 28564596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and biophysical characterization of ruthenation of BRCA1 RING protein by RAPTA complexes and its E3 ubiquitin ligase activity.
    Temboot P; Lee RFS; Menin L; Patiny L; Dyson PJ; Ratanaphan A
    Biochem Biophys Res Commun; 2017 Jun; 488(2):355-361. PubMed ID: 28501617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1 ubiquitylation of CtIP: Just the tIP of the iceberg?
    Barber LJ; Boulton SJ
    DNA Repair (Amst); 2006 Dec; 5(12):1499-504. PubMed ID: 17027345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highlight: BRCA1 and BRCA2 proteins in breast cancer.
    Daniel DC
    Microsc Res Tech; 2002 Oct; 59(1):68-83. PubMed ID: 12242698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BRCA1 ubiquitin ligase and homologous recombination repair.
    Ohta T; Sato K; Wu W
    FEBS Lett; 2011 Sep; 585(18):2836-44. PubMed ID: 21570976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.
    Parija S; Kumar A
    Int J Bioinform Res Appl; 2011; 7(1):1-14. PubMed ID: 21441093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation.
    Sankaran S; Crone DE; Palazzo RE; Parvin JD
    Cancer Res; 2007 Dec; 67(23):11186-94. PubMed ID: 18056443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
    Buck M
    Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
    Speit G; Trenz K
    Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.
    Sankaran S; Starita LM; Groen AC; Ko MJ; Parvin JD
    Mol Cell Biol; 2005 Oct; 25(19):8656-68. PubMed ID: 16166645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair.
    Abbott DW; Thompson ME; Robinson-Benion C; Tomlinson G; Jensen RA; Holt JT
    J Biol Chem; 1999 Jun; 274(26):18808-12. PubMed ID: 10373498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.